{"id":108882,"date":"2021-05-27T10:22:07","date_gmt":"2021-05-27T10:22:07","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=108882"},"modified":"2022-09-01T10:14:29","modified_gmt":"2022-09-01T10:14:29","slug":"kufs-disease","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/","title":{"rendered":"Kufs disease"},"content":{"rendered":"<p>Kufs disease is a late-onset variant of the neuronal ceroid lipofuscinoses (NCLs). There are four types of NCL, all of which have begun to be referred to as Batten disease. NCLs are inherited neurodegenerative storage disorders involving the accumulation of excessive abnormal lipo-pigments with fingerprint or granular ultrastructural patterns in the neurons and other cells throughout the central nervous system. This disease results in motor disturbances and neurological deficits that range in severity.<\/p>\n<hr \/>\n<p>An adult-onset, neuronal ceroid lipofuscinosis. The onset of symptoms is usually between 21 and 26 years, and always before 40. The disease is characterized by the development of dementia, myoclonic jerks, blindness, and retinitis pigmentosa.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kufs disease is a late-onset variant of the neuronal ceroid lipofuscinoses (NCLs). There are four types of NCL, all of which have begun to be referred to as Batten disease. NCLs are inherited neurodegenerative storage disorders involving the accumulation of excessive abnormal lipo-pigments with fingerprint or granular ultrastructural patterns in the neurons and other cells [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-108882","post","type-post","status-publish","format-standard","hentry","category-k"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Kufs disease - Definition of Kufs disease<\/title>\n<meta name=\"description\" content=\"Kufs disease is a late-onset variant of the neuronal ceroid lipofuscinoses (NCLs). There are four types of NCL, all of which have begun to be referred to as Batten disease. NCLs are inherited neurodegenerative storage disorders involving the accumulation of excessive abnormal lipo-pigments with fingerprint or granular ultrastructural patterns in the neurons and other cells throughout the central nervous system. This disease results in motor disturbances and neurological deficits that range in severity.An adult-onset, neuronal ceroid lipofuscinosis. The onset of symptoms is usually between 21 and 26 years, and always before 40. The disease is characterized by the development of dementia, myoclonic jerks, blindness, and retinitis pigmentosa.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kufs disease - Definition of Kufs disease\" \/>\n<meta property=\"og:description\" content=\"Kufs disease is a late-onset variant of the neuronal ceroid lipofuscinoses (NCLs). There are four types of NCL, all of which have begun to be referred to as Batten disease. NCLs are inherited neurodegenerative storage disorders involving the accumulation of excessive abnormal lipo-pigments with fingerprint or granular ultrastructural patterns in the neurons and other cells throughout the central nervous system. This disease results in motor disturbances and neurological deficits that range in severity.An adult-onset, neuronal ceroid lipofuscinosis. The onset of symptoms is usually between 21 and 26 years, and always before 40. The disease is characterized by the development of dementia, myoclonic jerks, blindness, and retinitis pigmentosa.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-27T10:22:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-01T10:14:29+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/\",\"name\":\"Kufs disease - Definition of Kufs disease\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-05-27T10:22:07+00:00\",\"dateModified\":\"2022-09-01T10:14:29+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Kufs disease is a late-onset variant of the neuronal ceroid lipofuscinoses (NCLs). There are four types of NCL, all of which have begun to be referred to as Batten disease. NCLs are inherited neurodegenerative storage disorders involving the accumulation of excessive abnormal lipo-pigments with fingerprint or granular ultrastructural patterns in the neurons and other cells throughout the central nervous system. This disease results in motor disturbances and neurological deficits that range in severity.An adult-onset, neuronal ceroid lipofuscinosis. The onset of symptoms is usually between 21 and 26 years, and always before 40. The disease is characterized by the development of dementia, myoclonic jerks, blindness, and retinitis pigmentosa.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kufs disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kufs disease - Definition of Kufs disease","description":"Kufs disease is a late-onset variant of the neuronal ceroid lipofuscinoses (NCLs). There are four types of NCL, all of which have begun to be referred to as Batten disease. NCLs are inherited neurodegenerative storage disorders involving the accumulation of excessive abnormal lipo-pigments with fingerprint or granular ultrastructural patterns in the neurons and other cells throughout the central nervous system. This disease results in motor disturbances and neurological deficits that range in severity.An adult-onset, neuronal ceroid lipofuscinosis. The onset of symptoms is usually between 21 and 26 years, and always before 40. The disease is characterized by the development of dementia, myoclonic jerks, blindness, and retinitis pigmentosa.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/","og_locale":"en_US","og_type":"article","og_title":"Kufs disease - Definition of Kufs disease","og_description":"Kufs disease is a late-onset variant of the neuronal ceroid lipofuscinoses (NCLs). There are four types of NCL, all of which have begun to be referred to as Batten disease. NCLs are inherited neurodegenerative storage disorders involving the accumulation of excessive abnormal lipo-pigments with fingerprint or granular ultrastructural patterns in the neurons and other cells throughout the central nervous system. This disease results in motor disturbances and neurological deficits that range in severity.An adult-onset, neuronal ceroid lipofuscinosis. The onset of symptoms is usually between 21 and 26 years, and always before 40. The disease is characterized by the development of dementia, myoclonic jerks, blindness, and retinitis pigmentosa.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/","og_site_name":"Glossary","article_published_time":"2021-05-27T10:22:07+00:00","article_modified_time":"2022-09-01T10:14:29+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/","name":"Kufs disease - Definition of Kufs disease","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-05-27T10:22:07+00:00","dateModified":"2022-09-01T10:14:29+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Kufs disease is a late-onset variant of the neuronal ceroid lipofuscinoses (NCLs). There are four types of NCL, all of which have begun to be referred to as Batten disease. NCLs are inherited neurodegenerative storage disorders involving the accumulation of excessive abnormal lipo-pigments with fingerprint or granular ultrastructural patterns in the neurons and other cells throughout the central nervous system. This disease results in motor disturbances and neurological deficits that range in severity.An adult-onset, neuronal ceroid lipofuscinosis. The onset of symptoms is usually between 21 and 26 years, and always before 40. The disease is characterized by the development of dementia, myoclonic jerks, blindness, and retinitis pigmentosa.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/kufs-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Kufs disease"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=108882"}],"version-history":[{"count":2,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108882\/revisions"}],"predecessor-version":[{"id":179959,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108882\/revisions\/179959"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=108882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=108882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=108882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}